Mystery of unexplained kidney disease revealed to patients

▴ kidney disease
In a significant finding, researchers at Newcastle University have discovered a new technique for assessing genomic data, which will eventually lead to a diagnosis for people suffering from renal failure that is yet undiagnosed.

                                                                                                                                     

April 7th, 2024: Newcastle University researchers have made a ground-breaking finding that has illuminated the mysterious causes of renal illnesses that remain unexplained. The work reveals a novel mechanism behind these illnesses and offers promise for improved diagnostics and treatments. It was published in the esteemed journal Genetics in Medicine Open. Medical practitioners have long been baffled by kidney disorders that go undiagnosed, giving patients few therapeutic options and frequently resulting in a steady deterioration in kidney function. Nonetheless, a noteworthy advancement has been achieved by Newcastle University's Deputy Dean of Biosciences, Professor John Sayer. 

 

After a thorough examination of tissue samples from afflicted individuals, the researchers discovered a genetic mutation that was previously unknown and associated with the emergence of renal disorders that are not understood. This mutation causes dysfunction and disease by interfering with an essential biological process that keeps the kidneys healthy. Kidney failure can have many causes, and if ignored, can be fatal. However, patients frequently do not receive a clear diagnosis, which can make it difficult to determine the best course of action. According to scientists, they have been able to categorize this as renal failure due to NPHP1 because they have now located the missing gene and discovered mutations within it.

 

Professor John Sayer states, "This finding represents a turning point in our understanding of kidney diseases that go undiagnosed. To provide the greatest results for our patients, we can now accurately diagnose some of them, enabling us to customize their monitoring, therapy, and investigative plans. We are now more qualified to identify and treat those who are impacted by these disorders, thereby averting additional kidney damage and enhancing patient outcomes, thanks to the discovery of their genetic foundation."

 

Ten additional UK patients with unexplained deafness and blindness who had previously been given no genetic explanation for their condition were also given new genetic diagnoses using the novel method, which involved analysing genomic data from 11,754 cases. Thanks to Professor Sayer's contribution to the Genomics England 100,000 Genomes project, which is mostly financed by Kidney Research UK and the Northern Counties Kidney Research Fund, the work was made feasible. Working with patient-derived cell lines, the Newcastle specialists are now able to investigate the illness process in greater depth and explore possible outcomes.

 

This work is a perfect example of the creative and cooperative research that Newcastle University is doing. Through the integration of disciplinary knowledge, scientists are achieving significant progress in comprehending and resolving intricate health issues. The study team's current priorities include looking at possible therapeutic interventions and delving deeper into the molecular mechanisms underlying the discovered genetic abnormality. Their ultimate objective is to provide patients with real advantages from these discoveries, giving them hope for better health and a higher standard of living.

 

Contribution from patients

 

Professor John Sayer added, “We were aware that many of our unresolved cases involved genetic disorders, and this new strategy allows us to find a conclusive solution in these circumstances. Our goal is to deliver a correct diagnosis for many more families in the future. We are now able to accurately diagnose many more renal disease-affected families genetically. In order to fully understand kidney failure, it is always important to look into its underlying causes, as this work serves as a reminder. The patient and other family members, particularly those who hope to give a kidney to a loved one, will be greatly affected if a genetic cause of renal failure is identified.”

 

Newcastle Health Innovation Partners (NHIP) includes both Newcastle Hospitals and Newcastle University. As one of the UK's eight esteemed Academic Health Science Centres (AHSCs), NHIP brings together collaborators to provide superior patient care, health education, and research.

 

ABOUT NEWCASTLE UNIVERSITY: Newcastle University, UK, is a thriving international community of more than 28,000 students from over 130 countries worldwide. As a member of the Russell Group of research-intensive universities in the UK, Newcastle has a world-class reputation for research excellence in the fields of medicine, science and engineering, social sciences and the humanities. Its academics are sharply focused on responding to the major challenges facing society today. Our research and teaching are world-leading in areas as diverse as health, culture, technology and the environment. Newcastle University is committed to providing our students with excellent, research-led teaching delivered by dedicated and passionate teachers. Newcastle University is ranked 110th  in the QS World Ranking 2024 and 139th in the Times Higher Education World University Ranking 2023.

Tags : #

About the Author


Team Medicircle

Related Stories

Loading Please wait...

-Advertisements-




Trending Now

Traditional Medicine Goes Global: How Ayush 2024 Reimagined WellnessDecember 26, 2024
Aster Guardians Global Nursing Award 2025 worth INR 2 Crore now open for nominations worldwide December 26, 2024
Holiday Season Round the Corner? 6 Daily Habits That Could Be The Reason Behind Your Fatty LiverDecember 26, 2024
Healing the Nation: Doctors as Architects of a Healthier FutureDecember 26, 2024
Brewing Health Benefits: Can Coffee and Tea Help Fight Head and Neck Cancers?December 26, 2024
Seven-Year-Old Fights Back Against Rare Autoimmune DiseaseDecember 26, 2024
Olympus Named to Dow Jones Sustainability World Index for the Fourth Consecutive YearDecember 26, 2024
American Oncology Institute (AOI) in Nagpur Restores Mobility with KyphoplastyDecember 26, 2024
Sanjeevani Healthcare & Wellness Expo 2024: A Dynamic Platform for Global Healthcare CollaborationDecember 23, 2024
Ranitidine: Saviour or Suspect? The Truth Behind the Stomach Acid RemedyDecember 23, 2024
From One-Size-Fits-All to Precision Medicine: The New Hope for Rare Bone Cancer PatientsDecember 23, 2024
World Meditation Day: India’s Gift of Peace to a Chaotic WorldDecember 23, 2024
Breaking New Ground in Migraine Care: A Landmark Session on Diagnosis and TreatmentDecember 23, 2024
Black Angels remind us of centuries of injustices plaguing the TB responseDecember 20, 2024
Healthcare Startups to Watch Out for in 2025December 20, 2024
Biobank Blueprint: Redefining Diabetes Diagnosis and Treatment in IndiaDecember 20, 2024
The Future of Malaria Prevention: Can This Vaccine Eliminate the Disease?December 20, 2024
Why the World Trusts Indian Pharmaceuticals for Life-Saving SolutionsDecember 20, 2024
International Tsunami Conference Concludes at AmritapuriDecember 20, 2024
Prestige Marks 75 Years of Revolutionizing Home Cooking with Iconic Innovative ProductsDecember 20, 2024